Kathleen R. Bartemes

Kathleen R. Bartemes

Auto-generated profile, based on publicly available information

Kathleen R. Bartemes

Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2024 in Communications Medicine
Verified
Journal Article
Open access
PDF file
SNSumanth Reddy Nakkireddy
Sumanth Reddy Nakkireddy
IJInyeop Jang
Inyeop Jang
MKMinji Kim
Minji Kim
LYLinda X. Yin
Linda X. Yin
MRMichael Rivera
Michael Rivera
THTae Hyun Hwang
Tae Hyun Hwang
Background Deep learning techniques excel at identifying tumor-infiltrating lymphocytes (TILs) and immune phenotypes in hematoxylin and eosin (H&E)-stained slides. However, their ability to elucidate detailed functional characteristics of diverse cellular phenotypes within tumor immune microenvironment (TME) is limited. We aimed to enhance our understanding of cellular composition and functional characteristics across TME regions and improve patient stratification by integrating H&E with adjacent immunohistochemistry (IHC) images. Methods A retrospective study was conducted on patients with Human Papillomavirus-positive oropharyngeal squamous cell carcinoma (OPSCC). Using paired H&E and IHC slides for 11 proteins, a deep learning pipeline was used to quantify tumor, stroma, and TILs in the TME. Patients were classified into immune inflamed (IN), immune excluded (IE), or immune desert (ID) phenotypes. By registering the IHC and H&E slides, we integrated IHC data to capture protein expression in the corresponding tumor regions. We further stratified patients into specific immune subtypes, such as IN, with increased or reduced CD8+ cells, based on the abundance of these proteins. This characterization provided functional insight into the H&E-based subtypes. Results Analysis of 88 primary tumors and 70 involved lymph node tissue images reveals an improved prognosis in patients classified as IN in primary tumors with high CD8 and low CD163 expression (p = 0.007). Multivariate Cox regression analysis confirms a significantly better prognosis for these subtypes. Conclusions Integrating H&E and IHC data enhances the functional characterization of immune phenotypes of the TME with biological interpretability, and improves patient stratification in HPV( + ) OPSCC.

18 February 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Purpose: Tumor-infiltrating lymphocytes are associated with a decreased risk of recurrence in human papillomavirus–associated oropharyngeal squamous cell carcinoma. The composition and spatial distribution of tumor-infiltrating lymphocytes and tumor-infiltrating immune cells are not well characterized. Experimental Design: Formalin-fixed, paraffin-embedded primary and lymph node (LN) tumor tissues from 10 progressors (cases) and 10 matched nonprogressors (controls) were interrogated by imaging mass cytometry. Immune, stromal, and tumor cells were quantified from selected regions of interest using machine learning. Nearest neighbors, cell–cell interactions, and niche analyses were performed. Results: In primary regions of interest, immune cell, lymphocyte, T cell, CD8+ T cell, and innate cell prevalence was significantly greater in controls. High prevalence of immune cells, lymphocytes, innate cells, and CD4+ T cells in primary tissues was significantly associated with increased time to event (TTE). Although primary and LN prevalence of T cells, CD4+ T cells, CD8+ T cells, macrophages, and tumor cells were significantly correlated, differences in LNs were neither significant nor associated with TTE. Average distances between T cells and the nearest B cells and between lymphocytes and the nearest tumor cells were decreased in control primary tissues. Interactions between B and T cells were less organized in primary tissues from cases. A niche predominantly comprising lymphocytes was associated with longer TTE. Conclusions: In human papillomavirus–associated oropharyngeal squamous cell carcinoma, immune cell subset prevalence in primary tumors differs with outcome and is associated with TTE. Interactions between B cells and both T-cell subsets are associated with longer TTE, underscoring the importance of active intratumoral immune responses in outcomes.

16 September 2023 in Oral Oncology
Verified
Journal Article
Closed access
KBKathleen R. Bartemes
Kathleen R. Bartemes
BGBenjamin R. Gochanour
Benjamin R. Gochanour
DRDavid M. Routman
David M. Routman
DMDaniel J. Ma
Daniel J. Ma
KDKaren A. Doering
Karen A. Doering
KAKathryn M Van Abel
Kathryn M Van Abel

15 September 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
BGBenjamin R. Gochanour
Benjamin R. Gochanour
DRDavid M. Routman
David M. Routman
KBKathleen R. Bartemes
Kathleen R. Bartemes
WTWilliam Taylor
William Taylor
DMDouglas W Mahoney
Douglas W Mahoney
KAKathryn M Van Abel
Kathryn M Van Abel
Background: Reliable non-invasive biomarkers for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPX) are lacking. We performed a discovery and validation study of methylated DNA markers (MDMs) for detection of OPX. In addition, we sought to evaluate the MDM profiles in saliva gargle samples from normal controls (nSAL). Methods: Formalin fixed paraffin embedded OPX and gender-balanced normal oropharyngeal tissue (NOP) were pathologically reviewed and punched for DNA extraction and sequenced using reduced representation bisulfite sequencing (RRBS). A tiling algorithm was used to define candidate MDMs. Highest ranked (e.g., area under the receiver operating characteristic curve (AUC), fold-change, p-value) candidate MDMs were validated by qMSP in independent OPX and NOP samples. nSAL DNA was used to assess MDM background signal. Discrimination between OPX tissue, NOP, and nSAL was assessed using AUC with corresponding 95% confidence intervals. HPV was confirmed with p16 staining or DNA in situ hybridization. Results: RRBS discovery assessed 18 OPX, 18 NOP, and 18 normal WBC samples. 234 MDM candidates from approximately 3 × 106 CpGs at >10X coverage were identified. 36 MDMs were selected for validation in independent patient samples which included 32 OPX, 36 NOP, and 35 nSAL specimens. OPX patients were older (median 51; IQR 45-54 years) than NOP patients (median 29; IQR 24-42). 69 and 61% of OPX and NOP patients were female, respectively. The majority of OPX patients were Stage I (n=27, 84%). We observed excellent discrimination between OPX and NOP in the validation set; the median AUC across 36 MDMs was 0.90 (IQR 0.87-0.95). The 10 highest performing markers (PARP15, EPDR1, SHROOM1, EMBP1.rs, IFFO1, MAX.chr19.118, ZNF763, ITGB4, FAM19A2, and MT1IP) exhibited AUCs ranging from 0.95-0.99. Strong discrimination was also observed between OPX and nSAL (Median AUC=0.97; IQR=0.93-0.99). All 10 of the highest-performing markers in tissue exhibited AUCs of at least 0.97 for discriminating OPX versus nSAL. Median fold change between NOP and nSAL across all MDMs was 1.9 (IQR 1.4-3.8), demonstrating low background signal in nSAL. Conclusions: We found strong discrimination in a panel of 36 MDMs between OPX case and control tissue as well as between OPX case tissue and normal saliva. The low background signal observed in normal saliva makes this media a strong candidate for non-invasive detection of OPX. Further studies are in development to assess the utility of measuring these MDMs in both case and control saliva and blood for detecting OPX non-invasively. Citation Format: Benjamin R. Gochanour, David M. Routman, Kathleen R. Bartemes, William R. Taylor, Douglas W. Mahoney, Rondell P. Graham, Xiaoming Cao, Calise K. Berger, Sara S. Then, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, John B. Kisiel, Kathryn M. Van Abel. Discovery and validation of methylated DNA markers of human papillomavirus associated oropharyngeal squamous cell carcinoma [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-039.

17 June 2026
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Composite of niche distributions from all control LN tissue ROIs

1 May 2025
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Graphic depictions of cell populations with no differences in FoxP3 expression between clinical groups and Kaplan-Meier plots comparing time to event for high and low levels of FoxP3 expression in cell populations from LN tumor tissues